Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK0782 + Aspirin Endoscopy Study
NCT00543465Phase 2Terminated
- Sponsor
- Merck & Co.
- Start
- Aug 2004
- Primary completion
- Nov 2004
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of laropiprant in osteoarthritis (OA), rheumatoid arthritis (RA), sponsored by Merck & Co.. Started Aug 2004; status: terminated.
02
Drugs
laropiprant
03
Conditions
osteoarthritis (OA)rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00543465.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00543465.